Sandu Pharmaceuticals Q3 Results
- BSE: 524703
- NSE: -
- ISIN: INE751D01014
- Sector: Biotechnology & Drugs
BSE
38.80
1.61 (4.33%)
1.61 (4.33%)Volume626.00
Updated: Fri 15 May, 2026 | 10:46:57
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹18.76 Cr.(2.11%)
- Operating Profit₹0.87 Cr.(9.16%)
- Profit After Tax₹0.98 Cr.(75.54%)
- Operating Margin4.66%(6.90%)
Note: Comparison is on YoY basis
Quarterly - Sandu Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 17.89 | 16.97 | 5.66% | 17.06 | 1.79% |
| Depreciation/ Amortization | 0.17 | 0.17 | -1.72% | 0.14 | -12.55% |
| Operating Income | 0.87 | 0.74 | 26.20% | 0.37 | 9.16% |
| Net Income | 0.98 | 0.50 | 86.02% | 0.21 | 75.54% |
| Other Operating Expenses Total | 7.19 | 6.03 | 24.03% | 5.76 | 34.02% |
| Net Income Before Taxes | 0.86 | 0.74 | 19.66% | 0.38 | 7.08% |
| Total Revenue | 18.76 | 17.70 | 6.47% | 17.43 | 2.11% |
| Selling/ General/ Admin Expenses Total | 2.65 | 2.61 | 0.33% | 2.53 | -16.17% |
| Diluted Normalized EPS | 1.01 | 1.95 | 87.04% | 0.21 | 77.19% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.